Nila Kartika Wati

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025

By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...

A New Era of Equity: Canada Establishes First-Ever National Standards for Breast Cancer Care a-new-era-of-equity-canada-establishes-first-ever-national-standards-for-breast-cancer-care

a-new-era-of-equity-canada-establishes-first-ever-national-standards-for-breast-cancer-care

A New Era of Equity: Canada Establishes First-Ever National Standards for Breast Cancer Care

Nila Kartika Wati August 15, 2025

In a landmark shift for the Canadian healthcare landscape, the nation’s preeminent breast cancer experts have officially...

The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research the-vanguard-of-hope-how-breast-cancer-canada-is-redefining-the-patient-experience-through-innovation-and-research

the-vanguard-of-hope-how-breast-cancer-canada-is-redefining-the-patient-experience-through-innovation-and-research

The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research

Nila Kartika Wati July 12, 2025

Introduction: A New Era in Oncology In the landscape of modern medicine, the fight against breast cancer...